Retatrutide
Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
$27.90
$30.00Dosage Summary: 3 x $27.90
For laboratory research use only. Not intended for human consumption.
Molecular Formula
C221H342N46O68
Purity
=>99.4%
Storage
-20°C
Half Life
6 days
About Retatrutide
Retatrutide (originally known as LY-3437943) is a highly effective, investigative multi-receptor agonist developed for the treatment of severe obesity and type 2 diabetes. By simultaneously activating the glucagon receptor (GCGR), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon-like peptide-1 receptor (GLP-1R), it works comprehensively to suppress appetite, enhance feelings of fullness, delay gastric emptying, and significantly increase energy expenditure. Clinical data indicates it provides substantial weight reduction profiles and highly robust glycemic control compared to earlier single or dual-receptor therapies.
Retatrutide is an experimental, synthetic triple-agonist peptide designed to target three primary metabolic receptors: GLP-1, GIP, and glucagon.
Store in a cool, dry environment: -20°C.
Certificate Of Analysis
Every batch undergoes rigorous third-party analytical testing to confirm purity, identity, and consistency standards.
Download COARelated Products
Fat Blaster (LC526)
LC526 Fat Blaster is a multi-component formulation designed for metabolic and fat-reduction research applications.
HGH Fragment 176–191
HGH Fragment 176–191 is a modified peptide fragment of human growth hormone studied for its …
Cagrilintide
Cagrilintide is a long-acting amylin analog studied for appetite suppression and weight management, often investigated …